| scholarly article | Q13442814 |
| P2093 | author name string | B. M. Spiegelman | |
| E. Hu | |||
| J. Devine | |||
| P. Tontonoz | |||
| E. G. Beale | |||
| P2860 | cites work | Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 |
| "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum | Q27860612 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription | Q28240186 | ||
| Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells | Q28240503 | ||
| SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene | Q28264180 | ||
| Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene | Q28286659 | ||
| Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators | Q28304744 | ||
| Identification of a thyroid hormone response element in the phosphoenolpyruvate carboxykinase (GTP) gene. Evidence for synergistic interaction between thyroid hormone and cAMP cis-regulatory elements | Q28304849 | ||
| Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors | Q28326688 | ||
| Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers | Q28378616 | ||
| The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development | Q28513428 | ||
| Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily | Q28578854 | ||
| Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors | Q29615768 | ||
| mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer | Q29617271 | ||
| Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors | Q34234016 | ||
| Control of specific protein biosynthesis during the adipose conversion of 3T3 cells. | Q34269065 | ||
| Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner | Q34699974 | ||
| ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation | Q36694542 | ||
| Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene | Q36724042 | ||
| The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP) | Q36774167 | ||
| Identification of basal and cyclic AMP regulatory elements in the promoter of the phosphoenolpyruvate carboxykinase gene | Q36793775 | ||
| A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation | Q36797244 | ||
| Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice | Q36962527 | ||
| Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression | Q36963264 | ||
| Differential regulation of the rat phosphoenolpyruvate carboxykinase gene expression in several tissues of transgenic mice | Q36964139 | ||
| A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene | Q37428862 | ||
| CCAAT-enhancer binding protein: a component of a differentiation switch | Q37624411 | ||
| Integration of multiple signals through a complex hormone response unit in the phosphoenolpyruvate carboxykinase gene promoter | Q38308604 | ||
| Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. | Q38343717 | ||
| Reciprocal regulation of adipogenesis by Myc and C/EBP alpha | Q41628463 | ||
| Identification of a potent adipocyte-specific enhancer: involvement of an NF-1-like factor | Q41692182 | ||
| Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. | Q42445534 | ||
| Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. | Q42610601 | ||
| Activation of the phosphoenolpyruvate carboxykinase gene retinoic acid response element is dependent on a retinoic acid receptor/coregulator complex | Q43183405 | ||
| Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice | Q52239276 | ||
| CAT vectors for analysis of eukaryotic promoters and enhancers. | Q54438149 | ||
| Yeast GCN4 as a probe for oncogenesis by AP-1 transcription factors: transcriptional activation through AP-1 sites is not sufficient for cellular transformation | Q68033260 | ||
| An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice | Q72272453 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 351–357 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene | |
| P478 | volume | 15 |
| Q27677636 | (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice |
| Q35683565 | 1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility |
| Q28138367 | A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus |
| Q40700524 | A futile metabolic cycle activated in adipocytes by antidiabetic agents |
| Q28609826 | A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs |
| Q42830605 | A peroxisome proliferator-response element in the murine mc2-r promoter regulates its transcriptional activation during differentiation of 3T3-L1 adipocytes |
| Q36671304 | A phase II trial with rosiglitazone in liposarcoma patients |
| Q42823314 | A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. |
| Q28475602 | A stem cell-based tool for small molecule screening in adipogenesis |
| Q38305514 | Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. |
| Q33633063 | Acute genome-wide effects of rosiglitazone on PPARγ transcriptional networks in adipocytes |
| Q42517347 | Adenovirus E1A proteins regulate phosphoenolpyruvate carboxykinase gene transcription through multiple mechanisms |
| Q40409381 | Adipocyte differentiation. When precursors are also regulators. |
| Q33918445 | Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes |
| Q37112231 | Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins |
| Q41193513 | Adipogenesis and obesity: rounding out the big picture |
| Q34983289 | Adipose depot-specific effects of PPAR gamma agonists: a consequence of differential expression of PPAR gamma in adipose tissue depots? |
| Q24803926 | Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease |
| Q33947244 | An adenosine receptor-Krüppel-like factor 4 protein axis inhibits adipogenesis |
| Q30349739 | An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. |
| Q42797565 | Anti-Obesity Activity of Saringosterol Isolated from Sargassum muticum (Yendo) Fensholt Extract in 3T3-L1 Cells. |
| Q37555511 | Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes |
| Q38304460 | Arsenic trioxide and microRNA-204 display contrary effects on regulating adipogenic and osteogenic differentiation of mesenchymal stem cells in aplastic anemia |
| Q37017152 | Association of FTO and PPARG polymorphisms with obesity in Portuguese women |
| Q54319581 | Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population. |
| Q41925102 | Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners |
| Q43148436 | Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO. |
| Q45249129 | Brown adipose tissue glyceroneogenesis is activated in rats exposed to cold. |
| Q35034570 | CD146+ human umbilical cord perivascular cells maintain stemness under hypoxia and as a cell source for skeletal regeneration |
| Q33961766 | CREB activation induces adipogenesis in 3T3-L1 cells |
| Q33955347 | Cell biology of peroxisomes and their characteristics in aquatic organisms |
| Q41159215 | Characterization of the human cytochrome P4502D6 promoter. A potential role for antagonistic interactions between members of the nuclear receptor family |
| Q37116337 | Chemical genomics of cancer chemopreventive dithiolethiones |
| Q35969865 | Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ |
| Q28508812 | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes |
| Q40962227 | Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells |
| Q39209941 | Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity |
| Q77545252 | Cross-talk between orphan nuclear hormone receptor RZRalpha and peroxisome proliferator-activated receptor alpha in regulation of the peroxisomal hydratase-dehydrogenase gene |
| Q33539473 | Cyclooxygenase-dependent signalling: molecular events and consequences |
| Q42835419 | DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region |
| Q44918616 | Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice. |
| Q24532889 | Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene |
| Q43128572 | Depot-specific effects of the PPARgamma agonist rosiglitazone on adipose tissue glucose uptake and metabolism. |
| Q37269408 | Developmental origin of adipocytes: new insights into a pending question. |
| Q34424728 | Dexamethasone stimulates leptin release from human adipocytes: unexpected inhibition by insulin |
| Q38291646 | Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue |
| Q44026609 | Differential effect of PPARgamma2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans |
| Q47954910 | Differentiation of mouse embryonic stem cells and of human adult stem cells into adipocytes |
| Q38356172 | Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma |
| Q40018541 | Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma |
| Q35073182 | ERK2-mediated phosphorylation of transcriptional coactivator binding protein PIMT/NCoA6IP at Ser298 augments hepatic gluconeogenesis |
| Q33876924 | Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. |
| Q41082278 | Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways |
| Q36465015 | Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone. |
| Q38295386 | Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma |
| Q33967843 | Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation |
| Q90281882 | Evidence for Adipocyte-Derived Extracellular Vesicles in the Human Circulation |
| Q42816137 | Evidence for selective induction of phosphoenolpyruvate carboxykinase gene expression by unsaturated and nonmetabolized fatty acids in adipocytes. |
| Q36164341 | FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance |
| Q28215944 | FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance |
| Q28252951 | Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C |
| Q34028463 | Fat cell metabolism: insulin, fatty acids, and renin |
| Q33437489 | Fat poetry: a kingdom for PPAR gamma |
| Q33996658 | Fatty acid regulation of gene transcription |
| Q42557816 | Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes |
| Q90169604 | Flow cytometry-based FRET identifies binding intensities in PPARγ1 protein-protein interactions in living cells |
| Q47367795 | Fucoxanthin and Its Metabolite Fucoxanthinol Do Not Induce Browning in Human Adipocytes |
| Q35067314 | Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells |
| Q38348333 | Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter |
| Q79202055 | Functional characterization of a peroxisome proliferator response-element located in the intron 3 of rat peroxisomal thiolase B gene |
| Q38516045 | Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor gamma and calcium signaling in human colorectal cancer cells |
| Q35184642 | G protein-coupled receptors and adipogenesis: a focus on adenosine receptors |
| Q53724496 | Genetic and ultrastructural demonstration of strong reversibility in human mesenchymal stem cell |
| Q44612173 | Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity |
| Q46650266 | Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit |
| Q42544180 | Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes. |
| Q38358139 | Glucocorticoids repress transcription of phosphoenolpyruvate carboxykinase (GTP) gene in adipocytes by inhibiting its C/EBP-mediated activation |
| Q42436779 | Glucocorticoids use a positive liver element to repress fibrate-induced adipose transcription of the phosphoenolpyruvate carboxykinase gene. |
| Q42088454 | Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat |
| Q37262563 | Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesis |
| Q41369732 | HIV-1 infection and the PPARγ-dependent control of adipose tissue physiology |
| Q42799800 | Hepatocyte nuclear factor 1b is a novel negative regulator of white adipocyte differentiation |
| Q41055050 | Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders |
| Q41756442 | IL-6-regulated transcription factors |
| Q62661503 | Identification and characterization of the human adipocyte apM-1 promoter |
| Q28144779 | Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma |
| Q42819880 | Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene |
| Q37599428 | Identification of the target proteins of rosiglitazone in 3T3-L1 adipocytes through proteomic analysis of cytosolic and secreted proteins. |
| Q36561243 | Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids |
| Q42817965 | Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia |
| Q34788395 | Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation |
| Q40776205 | Inhibition of myogenesis enables adipogenic trans-differentiation in the C2C12 myogenic cell line |
| Q43764271 | Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism |
| Q37317349 | Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution |
| Q40916791 | Intake of Total and Subgroups of Fat Minimally Affect the Associations between Selected Single Nucleotide Polymorphisms in the PPARγ Pathway and Changes in Anthropometry among European Adults from Cohorts of the DiOGenes Study. |
| Q41094816 | Involvement of HNF-1 in the regulation of phosphoenolpyruvate carboxykinase gene expression in the kidney |
| Q34025180 | Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice |
| Q34816136 | Is there a single mechanism for fatty acid regulation of gene transcription? |
| Q33983147 | Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? |
| Q30677523 | Isolation and characterization of the mouse cytosolic phosphoenolpyruvate carboxykinase (GTP) gene: evidence for tissue-specific hypersensitive sites |
| Q42814922 | Isolation of up- or down-regulated genes in PPARgamma-expressing NIH-3T3 cells during differentiation into adipocytes |
| Q42832497 | Kefir inhibits 3T3-L1 adipocyte differentiation through down-regulation of adipogenic transcription factor expression |
| Q28574330 | Leptin induces nitric oxide-mediated inhibition of lipolysis and glyceroneogenesis in rat white adipose tissue |
| Q24810578 | Linking dioxins to diabetes: epidemiology and biologic plausibility |
| Q46325454 | Linoleic acid stimulates gluconeogenesis via Ca2+/PLC, cPLA2, and PPAR pathways through GPR40 in primary cultured chicken hepatocytes |
| Q37900938 | Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. |
| Q42832215 | Lupenone isolated from Adenophora triphylla var. japonica extract inhibits adipogenic differentiation through the downregulation of PPARγ in 3T3-L1 cells |
| Q38185432 | Meta-review of protein network regulating obesity between validated obesity candidate genes in the white adipose tissue of high-fat diet-induced obese C57BL/6J mice |
| Q35613290 | Metabolic Functions of Peroxisome Proliferator-Activated Receptor beta/delta in Skeletal Muscle |
| Q80501209 | Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia |
| Q33701419 | Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4 |
| Q28589833 | Mitochondrial biogenesis and thyroid status maturation in brown fat require CCAAT/enhancer-binding protein alpha |
| Q41655698 | Modulating the transcriptional control of adipogenesis |
| Q36980325 | Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol |
| Q27015807 | Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications |
| Q28594397 | Modulator recognition factor-2 is required for adipogenesis in mouse embryo fibroblasts and 3T3-L1 cells |
| Q34666142 | Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. |
| Q58584067 | New Insights Regarding Genetic Aspects of Childhood Obesity: A Minireview |
| Q28370354 | Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects |
| Q33637047 | Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes |
| Q33563694 | Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation |
| Q41056915 | O-GlcNAcylation mediates the control of cytosolic phosphoenolpyruvate carboxykinase activity via Pgc1α |
| Q40379647 | Obesity-related genetic polymorphisms and adiposity indices in a young Italian population. |
| Q36465006 | PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. |
| Q57244390 | PPAR Tissue Distribution and Interactions with Other Hormone-Signaling Pathways |
| Q48958299 | PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. |
| Q34416432 | PPAR gamma and human metabolic disease |
| Q44295528 | PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly |
| Q41077493 | PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene |
| Q45115361 | PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease |
| Q37376857 | PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes |
| Q24311741 | PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL |
| Q33641441 | PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. |
| Q24633440 | PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 |
| Q42093464 | PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling |
| Q99711247 | PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice |
| Q52684405 | PPARγ and its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization. |
| Q35235884 | PPARγ population shift produces disease-related changes in molecular networks associated with metabolic syndrome. |
| Q37211826 | Pathophysiological Roles of PPARgamma in Gastrointestinal Epithelial Cells |
| Q37278866 | Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle |
| Q34236636 | Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes |
| Q74709718 | Peroxisome proliferator-activated receptor alpha and gamma agonists upregulate human macrophage lipoprotein lipase expression |
| Q24563197 | Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting |
| Q42094173 | Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux |
| Q40799456 | Peroxisome proliferator-activated receptor gamma and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. |
| Q24553023 | Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation |
| Q37367423 | Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids |
| Q42997461 | Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection |
| Q42830714 | Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity |
| Q33780711 | Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator |
| Q36454248 | Peroxisome proliferator-activated receptor-gamma: novel therapeutic target linking adiposity, insulin resistance, and atherosclerosis |
| Q37037626 | Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases |
| Q33867997 | Peroxisome proliferator-activated receptors: insight into multiple cellular functions |
| Q33796257 | Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions |
| Q41308170 | Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon |
| Q41519400 | Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism |
| Q35625043 | Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex |
| Q41844317 | Pin1 associates with and induces translocation of CRTC2 to the cytosol, thereby suppressing cAMP-responsive element transcriptional activity |
| Q42797844 | Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element |
| Q41862590 | Polyunsaturated fatty acids inhibit fatty acid synthase and spot-14-protein gene expression in cultured rat hepatocytes by a peroxidative mechanism. |
| Q37210865 | Preadipocyte transplantation: an in vivo study of direct leptin signaling on adipocyte morphogenesis and cell size |
| Q33998280 | Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors |
| Q35604703 | Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ). |
| Q37672105 | RNA-binding protein PSPC1 promotes the differentiation-dependent nuclear export of adipocyte RNAs |
| Q42818517 | Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalpha. |
| Q41431329 | Regulating adipogenesis |
| Q37355728 | Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. |
| Q42806955 | Regulation of PPAR gamma transcriptional activity in 3T3-L1 adipocytes |
| Q77582017 | Regulation of adipocyte gene expression by polyunsaturated fatty acids |
| Q36243028 | Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes |
| Q34243620 | Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages |
| Q33870610 | Regulation of fatty acid transporters in mammalian cells |
| Q41557177 | Regulation of gene transcription by fatty acids, fibrates and prostaglandins: the phosphoenolpyruvate carboxykinase gene as a model. |
| Q34920348 | Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis |
| Q39446637 | Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism |
| Q41317600 | Regulation of phosphoenolpyruvate carboxykinase gene transcription by thyroid hormone involves two distinct binding sites in the promoter |
| Q52174747 | Repression and activation of transcription of phosphoenolpyruvate carboxykinase gene during liver development. |
| Q40021186 | Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription |
| Q37799254 | Role of PPARα in Hepatic Carbohydrate Metabolism |
| Q58789254 | Role of murine macrophage in temporal regulation of cortisol- and serotonin-induced adipogenesis in pre-adipocytes when grown together |
| Q88779484 | Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation |
| Q37322310 | Rubi Fructus (Rubus coreanus) Inhibits Differentiation to Adipocytes in 3T3-L1 Cells |
| Q35408904 | S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis |
| Q42795820 | Shikonin inhibits fat accumulation in 3T3-L1 adipocytes |
| Q84635896 | Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population |
| Q24633409 | Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet |
| Q42834020 | Soyasaponins Aa and Ab exert an anti-obesity effect in 3T3-L1 adipocytes through downregulation of PPARγ. |
| Q41859391 | Stimulation of adipose differentiation related protein (ADRP) expression by ibuprofen and indomethacin in adipocyte precursors and in adipocytes |
| Q42829800 | Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes |
| Q39565699 | TLE3 is a dual-function transcriptional coregulator of adipogenesis |
| Q38316028 | Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation |
| Q42823164 | Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells |
| Q34737346 | Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. |
| Q90638915 | The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development |
| Q43904632 | The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor gamma ligands |
| Q39510036 | The contribution of IL-6 to beta 3 adrenergic receptor mediated adipose tissue remodeling |
| Q51002290 | The generation of adipocytes by the neural crest. |
| Q33994438 | The many facets of PPARgamma: novel insights for the skeleton |
| Q35051507 | The molecular control of adipogenesis, with special reference to lymphatic pathology |
| Q28510944 | The novel gene fad158, having a transmembrane domain and leucine-rich repeat, stimulates adipocyte differentiation |
| Q28244071 | The organization, promoter analysis, and expression of the human PPARgamma gene |
| Q34208083 | The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation |
| Q35004507 | The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro |
| Q33876311 | The role of oxygen availability in embryonic development and stem cell function |
| Q34286162 | The roles of PPARs in adipocyte differentiation |
| Q40621600 | The transcriptional regulation of phosphoenolpyruvate carboxykinase gene in the kidney requires the HNF-1 binding site of the gene |
| Q38301806 | The use of transgenic mice to analyze the role of accessory factor two in the regulation of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes |
| Q38641190 | Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future |
| Q36754403 | Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene |
| Q42805365 | Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues |
| Q38354039 | Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma |
| Q35544705 | Tissue-selective, bidirectional regulation of PEX11 alpha and perilipin genes through a common peroxisome proliferator response element |
| Q41101476 | Trans-differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazolidinediones |
| Q40646906 | Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARγ modulator |
| Q41139927 | Transcription, adipocyte differentiation, and obesity |
| Q42442743 | Transcriptional and posttranscriptional mechanisms of glucocorticoid-mediated repression of phosphoenolpyruvate carboxykinase gene expression in adipocytes |
| Q38331211 | Transcriptional control of the pref-1 gene in 3T3-L1 adipocyte differentiation. Sequence requirement for differentiation-dependent suppression |
| Q33874916 | Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha |
| Q28370770 | Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism |
| Q37285116 | Tumor necrosis factor-alpha induces caspase-mediated cleavage of peroxisome proliferator-activated receptor gamma in adipocytes |
| Q38316400 | Use of differentiating adult stem cells (marrow stromal cells) to identify new downstream target genes for transcription factors |
| Q33802801 | Uteroplacental insufficiency increases visceral adiposity and visceral adipose PPARgamma2 expression in male rat offspring prior to the onset of obesity |
| Q73866267 | Visualizing the expression of a human growth hormone (hGH) transgene in the liver: intrahepatic regional and intracellular differences of expression are associated with morphological alterations and hepatocellular proliferation |
Search more.